Gout clinical trials
14 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study of Dotinurad Versus Allopurinol in Participants With Gout
- SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial
- A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
- Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares
- Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
- Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
- Drug-Drug Interaction Study of ABP-671 in Gout Patients
- A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
- Dose Response of Exercise for Arthritis Management
- Improving Gout Care After an ED Visit
- Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
- Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Gout” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.